UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of December, 2022
|
001-41208 |
|
|
(Commission File Number) |
|
NOVONIX LIMITED
(Translation of registrant’s name into English)
Level 38
71 Eagle Street
Brisbane, QLD 4000 Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
Exhibit No. |
|
Description |
|
|
|
Exhibit 99.1 |
|
ASX Announcement (Change in Fiscal Year), dated December 21, 2022 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NOVONIX LIMITED
By: /s/ John Christopher Burns Dr. John Christopher Burns Chief Executive Officer |
|
|
|
Date: December 21, 2022
|
|
|
[NOVONIX LOGO]
ASX ANNOUNCEMENT
(ASX: NVX)
21 December 2022
NOVONIX Change of Financial Year to 31 December
NOVONIX Limited (NASDAQ: NVX, ASX: NVX, OTCQX: NVNXF) (“NOVONIX” or the “Company”) announces that its board of directors has resolved to change the
Company’s financial year end from 30 June to 31 December. The change is made to better align the reporting of the Company’s results with its industry peers.
NOVONIX has made the change in accordance with section 323D(2A) of the Corporations Act 2001 (Cth) and confirms that:
As a result of the introduction of the six-month transitional financial year, NOVONIX will lodge an annual financial report by 30 April 2023 for the period 01 July 2022 to 31 December
2022 and hold an annual general meeting by 31 May 2023.
This announcement has been authorized for release by NOVONIX Chairman, Admiral Robert J. Natter, USN Ret.
About NOVONIX
NOVONIX is a leading battery technology company with operations in both Canada and the United States. NOVONIX provides advanced, high-performance materials, equipment, and services for the global lithium-ion battery industry with sales in 14 countries. We develop materials and technologies to support longer-life and lower-cost batteries that are powering us towards a cleaner energy future.
Our NOVONIX Battery Technology Solutions division, based in Halifax, Nova Scotia, Canada, focuses on innovative battery research and development, along with providing advanced battery testing equipment and services on a global scale.
Our NOVONIX Anode Materials division, located in Chattanooga, Tennessee, USA, manufactures our synthetic graphite anode materials used to make lithium-ion batteries which power electric vehicles, personal electronics, medical devices, and energy storage units. To address the growing industry demand, we are working to increase the production capacity of our Riverside facility to 10,000 metric tons of synthetic graphite per annum (tpa), plan to add an incremental 30,000 tpa by 2025 and reach 150,000 tpa of total production by 2030.
To learn more about NOVONIX visit us on LinkedIn, Twitter, or www.novonixgroup.com
NOVONIX Limited (ASX: NVX)
ACN 157 690 830
Level 38, 71 Eagle Street
Brisbane QLD 4000
AUSTRALIA
For NOVONIX Limited
Scott Espenshade, ir@novonixgroup.com (investors)
Chantal Theoret, media@novonixgroup.com (media)
NOVONIX Limited (ASX: NVX)
ACN 157 690 830
Level 38, 71 Eagle Street
Brisbane QLD 4000
AUSTRALIA